BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fomin ME, Togarrati PP, Muench MO. Progress and challenges in the development of a cell-based therapy for hemophilia A. J Thromb Haemost 2014;12:1954-65. [PMID: 25297648 DOI: 10.1111/jth.12750] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Hartmann J, Croteau SE. 2017 Clinical trials update: Innovations in hemophilia therapy. Am J Hematol 2016;91:1252-60. [DOI: 10.1002/ajh.24543] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
2 Pipe SW, Gonen-Yaacovi G, Segurado OG. Hemophilia A Gene Therapy: Current and Next-Generation Approaches. Expert Opin Biol Ther 2021. [PMID: 34781798 DOI: 10.1080/14712598.2022.2002842] [Reference Citation Analysis]
3 Di Liddo R, Bertalot T, Borean A, Pirola I, Argentoni A, Schrenk S, Cenzi C, Capelli S, Conconi MT, Parnigotto PP. Leucocyte and Platelet-rich Fibrin: a carrier of autologous multipotent cells for regenerative medicine. J Cell Mol Med 2018;22:1840-54. [PMID: 29314633 DOI: 10.1111/jcmm.13468] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
4 Croteau SE, Wang M, Wheeler AP. 2021 clinical trials update: Innovations in hemophilia therapy. Am J Hematol 2021;96:128-44. [PMID: 33064330 DOI: 10.1002/ajh.26018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
5 Masi L, Ferrari S, Javaid MK, Papapoulos S, Pierroz DD, Brandi ML; IOF Skeletal Rare Diseases Working Group. Bone fragility in patients affected by congenital diseases non skeletal in origin. Orphanet J Rare Dis 2021;16:11. [PMID: 33407701 DOI: 10.1186/s13023-020-01611-5] [Reference Citation Analysis]
6 Balkaransingh P, Young G. Novel therapies and current clinical progress in hemophilia A. Ther Adv Hematol 2018;9:49-61. [PMID: 29387330 DOI: 10.1177/2040620717746312] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
7 Bernal S, Pelaez I, Alias L, Baena M, De Pablo-Moreno JA, Serrano LJ, Camero MD, Tizzano EF, Berrueco R, Liras A. High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies. Int J Mol Sci 2021;22:9705. [PMID: 34575869 DOI: 10.3390/ijms22189705] [Reference Citation Analysis]
8 Chen H, Shi M, Gilam A, Zheng Q, Zhang Y, Afrikanova I, Li J, Gluzman Z, Jiang R, Kong LJ, Chen-Tsai RY. Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII. Sci Rep 2019;9:16838. [PMID: 31727959 DOI: 10.1038/s41598-019-53198-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Jamil MA, Singer H, Al-Rifai R, Nüsgen N, Rath M, Strauss S, Andreou I, Oldenburg J, El-Maarri O. Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells. Int J Mol Sci 2020;21:E7776. [PMID: 33096636 DOI: 10.3390/ijms21207776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wang Q, Dong B, Firrman J, Wu W, Roberts S, Moore AR, Liu LS, Chin MP, Diao Y, Kost J, Xiao W. Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment. Gene Ther 2016;23:597-605. [PMID: 27064790 DOI: 10.1038/gt.2016.34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
11 Arruda VR. The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A. Haematologica 2015;100:849-50. [PMID: 26130509 DOI: 10.3324/haematol.2015.129858] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Ten Cate H, Hackeng TM, García de Frutos P. Coagulation factor and protease pathways in thrombosis and cardiovascular disease. Thromb Haemost 2017;117:1265-71. [PMID: 28594052 DOI: 10.1160/TH17-02-0079] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
13 Sun Q, Liu X, Wu Y, Niu W, Long P, Liu J, Lei M, Hu Y, Wu L, Li Z, Liang D. Ectopic expression of factor VIII in MSCs and hepatocytes derived from rDNA targeted hESCs. Clin Chim Acta 2019;495:656-63. [PMID: 30096315 DOI: 10.1016/j.cca.2018.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Fomin ME, Beyer AI, Muench MO. Human fetal liver cultures support multiple cell lineages that can engraft immunodeficient mice. Open Biol 2017;7:170108. [PMID: 29237808 DOI: 10.1098/rsob.170108] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
15 Yamaki Y, Fukushima T, Yoshida N, Nishimura K, Fukuda A, Hisatake K, Aso M, Sakasai T, Kijima-Tanaka J, Miwa Y, Nakanishi M, Sumazaki R, Takada H. Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A. Int J Hematol 2021;113:493-9. [PMID: 33385293 DOI: 10.1007/s12185-020-03059-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Monahan PE. Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors. Hematology Am Soc Hematol Educ Program 2015;2015:33-40. [PMID: 26637698 DOI: 10.1182/asheducation-2015.1.33] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
17 Dilip Kumar S, Aashabharathi M, KarthigaDevi G, Subbaiya R, Saravanan M. Insights of CRISPR-Cas systems in stem cells: progress in regenerative medicine. Mol Biol Rep 2021. [PMID: 34687393 DOI: 10.1007/s11033-021-06832-w] [Reference Citation Analysis]
18 Pang J, Wu Y, Li Z, Hu Z, Wang X, Hu X, Wang X, Liu X, Zhou M, Liu B, Wang Y, Feng M, Liang D. Targeting of the human F8 at the multicopy rDNA locus in Hemophilia A patient-derived iPSCs using TALENickases. Biochem Biophys Res Commun 2016;472:144-9. [PMID: 26921444 DOI: 10.1016/j.bbrc.2016.02.083] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
19 Mishra A, Arindkar S, Sahay P, Kumar JM, Upadhyay PK, Majumdar SS, Nagarajan P. Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model. Int J Exp Pathol 2018;99:46-53. [PMID: 29656466 DOI: 10.1111/iep.12264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]